Pliant Therapeutics
Redwood City, CA
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant’s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
pliantrx.comCompany Details
Founded
- 2016
Employees
- Between 100 - 500 employees
Raised
- $694,945,152
Headquarters Location
- Redwood City, CA
Public
- Yes
Acquired
- No
CEO
- Bernard Coulie
Founders
- Dean SheppardWilliam DeGradoBradley BackesHal Chapman
Company Collections
These are collections Pliant Therapeutics is a part of. Click on the collection name to view similar companies.